A comparative study between the severe acute respiratory syndrome-Coronavirus-2, severe acute respiratory syndrome coronavirus, and the middle east respiratory syndrome coronavirus

被引：6

作者：

Ibn Asaduzzaman, Syed Abdullah ^{[1
]}

Zakaria, Amayna ^{[1
]}

Kheya, Ilora Shabnam ^{[1
]}

Fahad, Nazmul ^{[1
]}

Sikandar, Yusra Binte ^{[1
]}

Noor, Rashed ^{[1
]}

机构：

[1] Independent Univ Bangladesh IUB, Sch Life Sci SLS, Dept Microbiol, Dhaka, Bangladesh

来源：

BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL | 2020年 / 4卷 / 05期

关键词：

COVID-19; pandemic; Middle East respiratory syndrome coronavirus; public health; SARS-CoV; severe acute respiratory syndrome-coronavirus-2; MERS-COV INFECTION; VIRUS; PATHOGENESIS;

D O I：

10.4103/bbrj.bbrj_99_20

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is of public health emergency of international concern. Within the last two decades, the prevalence of the epidemics by the acute respiratory syndrome coronavirus (SARS-CoV) and by the Middle East respiratory syndrome coronavirus has also been observed. Therefore, regarding these three coronaviruses, certain critical issues have been focused in the current review concerning their evolution and transmission, genomic influence on the corresponding virulence, immunopathogenesis, and the preventive measures including the vaccination strategies and the antiviral therapies.

引用

页码：65 / 74

页数：10

共 37 条

[31] Recent advances in understanding viral evasion of type I interferon [J].

Taylor, Kathryne E. ;

Mossman, Karen L. .

IMMUNOLOGY, 2013, 138 (03) :190-197

[32] Interplay between coronavirus, a cytoplasmic RNA virus, and nonsense-mediated mRNA decay pathway [J].

Wada, Masami ;

Lokugamage, Kumari G. ;

Nakagawa, Keisuke ;

Narayanan, Krishna ;

Makino, Shinji .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (43) :E10157-E10166

[33]

Wan YS, 2020, J VIROL, V94, DOI [10.1128/JVI.02015-19, 10.1128/JVI.00127-20]

[34]

WHO, 2020, Coronavirus Disease COVID-19) Technical Guidance: Laboratory Testing for 2019-nCoV in Humans

[35] Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods [J].

Wu, Canrong ;

Liu, Yang ;

Yang, Yueying ;

Zhang, Peng ;

Zhong, Wu ;

Wang, Yali ;

Wang, Qiqi ;

Xu, Yang ;

Li, Mingxue ;

Li, Xingzhou ;

Zheng, Mengzhu ;

Chen, Lixia ;

Li, Hua .

ACTA PHARMACEUTICA SINICA B, 2020, 10 (05) :766-788

[36] Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion [J].

Xia, Shuai ;

Liu, Meiqin ;

Wang, Chao ;

Xu, Wei ;

Lan, Qiaoshuai ;

Feng, Siliang ;

Qi, Feifei ;

Bao, Linlin ;

Du, Lanying ;

Liu, Shuwen ;

Qin, Chuan ;

Sun, Fei ;

Shi, Zhengli ;

Zhu, Yun ;

Jiang, Shibo ;

Lu, Lu .

CELL RESEARCH, 2020, 30 (04) :343-355

[37]

Xu Jing, 2003, Genomics Proteomics & Bioinformatics, V1, P226

← 1 2 3 4 →